Conceptual, methodological, and ethical problems in communicating uncertainty in clinical evidence.
about
The value of personalised risk information: a qualitative study of the perceptions of patients with prostate cancer.Against conventional wisdom: when the public, the media, and medical practice collide.Assessing Patient-Centered Communication in Cancer Care: Measures for Surveillance of Communication OutcomesA taxonomy of medical uncertainties in clinical genome sequencingAn exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testingSocial and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group.How do research participants perceive "uncertainty" in genome sequencing?A typology of uncertainty derived from an analysis of critical incidents in medical residents: A mixed methods study.General Practitioners' Experiences of, and Responses to, Uncertainty in Prostate Cancer Screening: Insights from a Qualitative StudyPerceived ambiguity as a barrier to intentions to learn genome sequencing results.Known unknowns: building an ethics of uncertainty into genomic medicineConflicting health information: a critical research need.Animated randomness, avatars, movement, and personalization in risk graphics."We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer.Genetic risk models: Influence of model size on risk estimates and precision.Communicating Uncertainty in Benefits and Harms: A Review of Patient Decision Support Interventions.The Role of the Message Convergence Framework in Medical Decision Making.onlineDeCISion.org: a web-based decision aid for DCIS treatment.Factors Affecting Physicians' Intentions to Communicate Personalized Prognostic Information to Cancer Patients at the End of Life: An Experimental Vignette Study.The Influence of Weight-of-Evidence Messages on (Vaccine) Attitudes: A Sequential Mediation Model.Communicating Uncertain Science to the Public: How Amount and Source of Uncertainty Impact Fatalism, Backlash, and Overload.Stakeholders' rationales for representing uncertainties of biotechnological research.Patient perspectives on how physicians communicate diagnostic uncertainty: An experimental vignette study.Physicians' perceptions of the value of prognostic models: the benefits and risks of prognostic confidence.Balancing Genetics (Science) and Counseling (Art) in Prenatal Chromosomal Microarray Testing.Including "evidentiary balance" in news media coverage of vaccine risk.The epigenetic effects of assisted reproductive technologies: ethical considerations.Patient-Centered Obstetric Care in the Age of Cell-Free Fetal DNA Prenatal Screening.Communication of Scientific Uncertainty about a Novel Pandemic Health Threat: Ambiguity Aversion and Its Mechanisms.Scrutinizing screening: a critical interpretive review of primary care provider perspectives on mammography decision-making with average-risk women.Preferences for ‘New’ Treatments Diminish in the Face of Ambiguity
P2860
Q30544850-D5B87399-C377-4ADC-B253-25AA16F3B125Q33645368-A5A95574-7464-4F3B-BD69-ED2A82CF23F6Q33756776-06B19140-EFDF-47A6-B34E-B2DEDE3075DEQ33918222-FFFDC144-5888-4561-AB32-DF2DA8617091Q34099702-2C46C102-E5BE-4B39-B809-F3DC1A689560Q34175545-636267C6-BA10-42B0-AA52-36506C40F20AQ34587712-2F5F8EC6-927F-435E-98DF-5B89F3282596Q35832514-15F1E37D-BD8E-443D-AB95-115EAACD1325Q35995860-4C289EF4-DB9F-449F-BC93-7AE9B1F0D044Q36055126-0600078A-0C58-4611-A294-8EC321DFF227Q36120680-2E2FA3D8-ACE3-4508-A451-C63C68B629AFQ37476487-2A16994C-87A6-47BC-BCB6-C5B250ACD314Q37689903-9A46EFC7-91A9-4C47-9A4A-AACB20ABE6FEQ38754318-E85A7882-9EC3-4DA9-B071-7CDF12215663Q38816720-2EEBDF9F-2479-4C02-91C7-1126F0E7A5A7Q38961006-17D26A43-F65F-43E7-A7CC-B524EF602DF9Q39025266-21BCFEAD-31C4-439B-88FA-E858F1156FDCQ40717691-FB877651-EAB5-4246-B40A-8067BE18BAB9Q41207349-2D0DD145-8BA7-48C9-87A6-B7C75B0F5946Q42438394-69F71D3A-8D4C-4A47-AD7E-A9951C0F2016Q45016851-3A7173FD-E273-4A05-B9D2-0383CB08C65CQ47153582-B320BB5A-6DF4-4958-A410-A7B7B62C479CQ47622533-1B54EA0F-EA0E-42E0-87D4-E6346C4CD81BQ47656952-8A501F91-C4D9-4BD2-83A9-4E6A07256222Q49249250-FDCBC15D-B232-4336-AB45-EA492EF7EAB9Q50209301-A2248E9E-9898-4158-940A-5213667C4835Q50305917-B2F2E7AF-22EC-4123-81C7-981DD6DFF25EQ50437193-92C12A00-5D50-4FB6-82D6-412EA944444AQ52340854-452DDCF3-C1FB-492C-94F9-16FF577A0DCDQ52592013-7A7998C4-DB35-49FA-AACA-53B05D6526F6Q55224244-DDC23787-527C-4DD5-847C-8F2BF5AF3933Q57994139-B7791931-C771-442B-B4A2-775AB53F0B7D
P2860
Conceptual, methodological, and ethical problems in communicating uncertainty in clinical evidence.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Conceptual, methodological, an ...... ertainty in clinical evidence.
@ast
Conceptual, methodological, an ...... ertainty in clinical evidence.
@en
Conceptual, methodological, an ...... ertainty in clinical evidence.
@nl
type
label
Conceptual, methodological, an ...... ertainty in clinical evidence.
@ast
Conceptual, methodological, an ...... ertainty in clinical evidence.
@en
Conceptual, methodological, an ...... ertainty in clinical evidence.
@nl
prefLabel
Conceptual, methodological, an ...... ertainty in clinical evidence.
@ast
Conceptual, methodological, an ...... ertainty in clinical evidence.
@en
Conceptual, methodological, an ...... ertainty in clinical evidence.
@nl
P2860
P356
P1476
Conceptual, methodological, an ...... certainty in clinical evidence
@en
P2093
Paul K J Han
P2860
P304
P356
10.1177/1077558712459361
P433
P50
P577
2012-11-06T00:00:00Z